CERIBELL, INC. (CBLL)

Blumberg Scott 🟡 adjusted position in 34.5K shares (4 derivative) of Ceribell, Inc. (CBLL) at $25.03 ($1.4M) Transaction Date: Aug 18, 2026 | Filing ID: 359672

Register to leave comments

  • News bot Aug. 21, 2026, 12:56 a.m.

    🔍 Blumberg Scott (Executive)

    Company: Ceribell, Inc. (CBLL)

    Report Date: 2026-08-18

    Transaction Summary:

    • Total transactions: 10
    • Derivative instruments: 4
    • Holdings reported: 0
    • Total shares acquired: 34,502
    • Total shares sold: 69,004

    Detailed Transactions and Holdings:

    • Acquired 690 shares of Common Stock at $4.7 per share (Direct)
      Date: 2026-08-18 | Code: M | equity_swap_involved: false | shares_owned_after: 148,811.00 | transaction_form_type: 4 | Footnotes: F1, F2
    • Acquired 300 shares of Common Stock at $9.41 per share (Direct)
      Date: 2026-08-18 | Code: M | equity_swap_involved: false | shares_owned_after: 149,111.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 990 shares of Common Stock at $25.0 per share (Direct)
      Date: 2026-08-18 | Code: S | equity_swap_involved: false | shares_owned_after: 148,121.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 6,179 shares of Common Stock at $4.7 per share (Direct)
      Date: 2026-08-19 | Code: M | equity_swap_involved: false | shares_owned_after: 154,300.00 | transaction_form_type: 4 | Footnotes: F1
    • Acquired 27,333 shares of Common Stock at $9.41 per share (Direct)
      Date: 2026-08-19 | Code: M | equity_swap_involved: false | shares_owned_after: 181,633.00 | transaction_form_type: 4 | Footnotes: F1
    • Sold 33,512 shares of Common Stock at $25.03 per share (Direct)
      Date: 2026-08-19 | Code: S | equity_swap_involved: false | shares_owned_after: 148,121.00 | transaction_form_type: 4 | Footnotes: F1, F3
    • Sold 690 shares of Stock Option (Right to Buy) at $4.7 per share (Derivative)
      Date: 2026-08-18 | Code: M | Expires: 2033-02-16 | equity_swap_involved: false | shares_owned_after: 43,403.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 300 shares of Stock Option (Right to Buy) at $9.41 per share (Derivative)
      Date: 2026-08-18 | Code: M | Expires: 2034-04-23 | equity_swap_involved: false | shares_owned_after: 80,633.00 | transaction_form_type: 4 | Footnotes: F1, F5
    • Sold 6,179 shares of Stock Option (Right to Buy) at $4.7 per share (Derivative)
      Date: 2026-08-19 | Code: M | Expires: 2033-02-16 | equity_swap_involved: false | shares_owned_after: 37,224.00 | transaction_form_type: 4 | Footnotes: F1, F4
    • Sold 27,333 shares of Stock Option (Right to Buy) at $9.41 per share (Derivative)
      Date: 2026-08-19 | Code: M | Expires: 2034-04-23 | equity_swap_involved: false | shares_owned_after: 53,300.00 | transaction_form_type: 4 | Footnotes: F1, F5

    Footnotes:

    • F1: The transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 12, 2025.
    • F2: Includes 438 shares acquired under the Issuer's Employee Stock Purchase Plan on July 31, 2026.
    • F3: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $25 to $25.16, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased or sold, as applicable, at each separate price within the ranges set forth in this footnote.
    • F4: The option vests with respect to 1/48 of the shares subject thereto on each monthly anniversary of April 1, 2023, subject to the Reporting Person's continued employment or service relationship with the Issuer on each such vesting date.
    • F5: The stock option is fully vested and currently exercisable.